1
|
Zhu Y, Lu S, Bian X, Wang H, Zhu B, Wang H, Xu Z, Xu L, Yan W, Zeng Y, Chen Z, Tang S, Shen G, Miao Z. A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age. Taiwan J Obstet Gynecol 2017; 55:379-84. [PMID: 27343319 DOI: 10.1016/j.tjog.2016.01.002] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/05/2016] [Indexed: 10/21/2022] Open
Abstract
OBJECTIVE This study aimed to determine the rates of different fetal chromosomal abnormalities among women of advanced maternal age in China and to discuss the possible misdiagnosis risks of newer molecular techniques, for selection of appropriate prenatal screening and diagnostic technologies. MATERIALS AND METHODS Second trimester amniocentesis and fetal karyotype results of 46,258 women were retrospectively reviewed. All women were ≥ 35 years old with singleton pregnancies. The rates of clinically significant chromosomal abnormalities (CSCAs), incidence of chromosomal abnormalities, and correlations with age were determined. RESULTS From 2001 to 2010, the proportion of women of advanced maternal age undergoing prenatal diagnosis increased from 20% to 46%. The mean age was 37.4 years (range, 35-46 years). A total of 708 cases of CSCAs, with a rate of 1.53% were found. Trisomy 21 was the most common single chromosome abnormality and accounted for 55.9% of all CSCAs with an incidence of 0.86%. Trisomy 13, trisomy 18, and trisomy 21, the most common chromosome autosomal aneuploidies, accounted for 73.6% of all CSCAs, with a rate of 1.13%. As a group, the most common chromosomal aneuploidies (13/18/21/X/Y) accounted for 93.9% of all abnormalities, with a rate of 1.44%. The incidence of trisomy 21, trisomy 13/18/21 as a group, and 13/18/21/X/Y as a group was significantly greater in women aged 39 years and older (p < 0.001), but was not different between women aged 35 years, 36 years, 37 years, and 38 years. CONCLUSION These findings may assist in genetic counseling of advanced maternal age pregnant women, and provide a basis for the selection of prenatal screening and diagnostic technologies.
Collapse
Affiliation(s)
- Yuning Zhu
- Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Prenatal Diagnosis Center of Zhejiang Province, Hangzhou, China
| | - Shiming Lu
- Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Prenatal Diagnosis Center of Zhejiang Province, Hangzhou, China.
| | - Xuming Bian
- Department of Obstetrics and Gynecology, Academy of Medical Science, Chinese Peking Union Medical College, Peking Union Medical College Hospital, Beijing, China
| | - He Wang
- West China Second University Hospital, Sichuan University, Prenatal Diagnosis Center of Sichuan Province, Chengdu, China
| | - Baosheng Zhu
- Genetic Diagnostic Center, the First People's Hospital of Yunnan Province, Kunming, China
| | - Hua Wang
- The Maternal and Child Health Hospital of Hunan Province, Prenatal Diagnosis Center of Hunan Province, Changsha, Hunan, China
| | - Zhengfeng Xu
- Center of Prenatal Diagnosis, Nanjing Maternity and Child Health Care Hospital, Nanjing, China
| | - Liangpu Xu
- Center of Prenatal Diagnosis, Maternal and Child Health Hospital of Fujian Province, Fuzhou, China
| | - Weihua Yan
- Center of Prenatal Diagnosis, Taizhou Hospital, Taizhou, China
| | - Yan Zeng
- Center of Prenatal Diagnosis, Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China
| | - Zhiyang Chen
- Center of Prenatal Diagnosis, Ningbo Maternity and Child Health Care Hospital, Ningbo, China
| | - Shaohua Tang
- Center of Prenatal Diagnosis, Wenzhou Central Hospital, Wenzhou, China
| | - Guosong Shen
- Center of Prenatal Diagnosis, Huzhou Maternity and Child Health Care Hospital, Huzhou, China
| | - Zhengyou Miao
- Center of Prenatal Diagnosis, Jiaxing Maternity and Child Health Care Hospital, Jiaxing, China
| |
Collapse
|
2
|
ÖZER KAYA Ö, KOÇ A, ÖZDEMİR TR, KIRBIYIK Ö, ÖZYILMAZ B, ÖZEREN M, ÖZTEKİN DC, TANER CE, KUTBAY YB. QF-PCR in invasive prenatal diagnosis: a single-center experience in Turkey. Turk J Med Sci 2017; 47:142-147. [DOI: 10.3906/sag-1511-157] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2015] [Accepted: 05/15/2016] [Indexed: 11/03/2022] Open
|